China based TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designa...
Hutchison China MediTech has announced that the independent Data Monitoring Committee (“IDMC”) of the P...
Australia based Propanc Biopharma, Inc., a biopharmaceutical company developing new cancer treatments for patients suffe...
Zydus, a leading discovery based global pharmaceutical company based in India has announced that it has entered into a l...
Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutic...
Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be construct...
Novartis Malaysia, a global leader in the healthcare space has been awarded the Top Employer for...
Malaysian Organisation of Pharmaceutical Industries (MOPI) is organising 'International Good Manufacturing T...
Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven&r...
Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics...
The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Mo...
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo C...
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into...
A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Ph...
BioMed X on 13 Jan 2020 announced the start of a new joint research group in collaboration with Boehringer Ingelhei...
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for the number of studies...
EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization ag...
Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, has announced that QLETLI®, a biosimilar to Hu...
Mundipharma has announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar can...
Eli Lilly and Company and Dermira, Inc. have announced a definitive agreement for Lilly to acquire Dermira&nbs...
Boehringer Ingelheim and Singapore based Enleofen Bio Pte. Ltd. (Enleofen) have announced the acquisition of worldwide e...
Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreem...
US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointm...
Hikma Pharmaceuticals PLC, Dubai (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic pharmace...
The Antengene board has announced the appointment of Mr. Mark J. Alles as an independent director of the compa...
